Cambridge Catalogue  
  • Help
Home > Catalogue > Pocket Guide for Cutaneous Medicine and Surgery
Pocket Guide for Cutaneous Medicine and Surgery
Google Book Search

Search this book

Details

  • Page extent: 0 pages

Adobe eBook Reader

 (ISBN-13: 9780511343483)




INDEX

abducens nerve (CN VI), 5

Acyclovir, 117

adalimumab (Humira®), 129

admission orders, 3

alefacept (Amevive®), 129–130

anesthesia. See local anesthesia; topical anesthesia

angioedema, 71–72

angioid streaks (“EIC Shop), 205

antibacterials. See systemic antibacterials

antibiotic prophylaxis

   antibiotics, 44

   indications, 44

   indications (AHA guidelines), 43

   risk factors, 43

anticoagulants and mechanisms, 46

antigens

   in dermatologic diseases, 152–153

   in paraneoplastic pemphigus, 153

antihistamines, 137

antimalarial agents, 127–128

antimicrobials. See topical antimicrobials

antinuclear antibodies, 82

   antibody, 82

   disorder, 82

   pattern, 82

   target, 82

antiseptic cleaners, 30

antivirals. See systemic antivirals

anti-Xa (unfractionated heparin anti-Xa; LMWH anti-Xa), 48

arteries, facial, 16–17

autosomal dominant diseases, 174–175

   disease, 174–175

   gene, 174–175

autosomal recessive diseases, 176–177

   disease, 176–177

   gene, 176–177

azathioprine (Imuran), 122–123

Azithromycin (macrolide [azalide]), 107

Bacitracin, 112

bacteriology

   gram negative, 57

   gram positive, 57

biologics, 129–131

bleeding disorders, 50

blue lunulae (“warp”), 205

blue sclera (“gins poem”), 205

botox cosmetic, 37

buccal nerve, 14

carcinoma, basal cell, AJCC staging for, 94

carcinoma, cutaneous squamous cell

   AJCC staging for, 94

   histologic grading of, 95

Cephalexin (cephalosporin), 107–108

cervical nerve, 15

Chanarin-Dorfman syndrome (“idle PM”), 205

chemical peels

   deep, 36

   medium, 36

   superficial, 36

chemotherapy-induced hyperpigmentation, 206

CHILD syndrome, 206

chlorhexidine (Hibiclens™), 30

chloroquine (Aralen), 127

chromoblastomycosis, 206

Churg-Strauss syndrome (“beansap”), 206–207

Ciprofloxacin (quinolone), 108

Clindamycin, 110–111

closure time-PFA-100 (platelet function assay), 48

coagulation cascade, 45

Colchicine, 139

collagen, 148–149

   chromosome, 148–149

   disease, 148–149

   tissue distribution, 148–149

   type, 148–149

complement system, 67

Conradi-Hunermann syndrome (“Conradi”), 207

corticosteroid potency, 136

   intermediate, 136

   long-acting, 136

   short acting, 136

Cowden’s syndrome (“got tuba”), 207

CPY 2C9 inducers and inhibitors, 208–209

CPY 2D6 inducers and inhibitors, 209

cranial nerves, 4–6

   abducens (VI), 5

   facial (VII), 5

   glossopharyngeal (IX), 5–6

   hypoglossal (XII), 6

   oculomotor (III), 4

   olfactory (I), 4

   optic (II), 4

   spinal accessory (XI), 6

   trigeminal (V), 5

   trochlear (IV), 4

   vagal ((X), 6

   vestibulocochlear (VIII), 5

CREST syndrome, 207

cutaneous leishmaniasis, 163

cutaneous T-cell lymphomas (CTCL), 96

cyclophosphamide (Cytoxan), 125

cyclosporine (Neoral), 123

CYP 1A2 inducers and inhibitors, 208

CYP 3A4 inducers and inhibitors, 209

cytochrome P-450 inducers (general), 208

cytochrome P-450 inhibitors (general), 208

cytotoxic agents, 125–126

Dapsone, 121

dermatology lists, 205, 226

dermatology mnemonics, 205, 226

dermatomes, 6–7

dermatopathology, “bodies” in, 223

dermis

   big blue balls in, 223

   busy, 224

Dicloxacillin (β-lactamase resistant penicillin), 107

diffuse cutaneous leishmaniasis, 163

disease, dermatologic

   antigen, 152–153

   disease, 152–153

   size (kD), 152–153

diseases, etiology of, 164–173

DNA viruses, 59

Doxycycline (tetracycline), 105

drugs, miscellaneous, 139–141

dyskeratosis congenita (“plans”), 210

ectothrix infections, 211–212

efaluzimab (Raptiva®), 130

electrosurgery

   biterminal, 29

   electrocautery, 29

   monoterminal, 29

endothrix infections, 212

eosinophilic spongiosis (“see a chip”), 224

epidermolysis bullosa, 86

   dermolytic or dystrophic, 86–87

   intraepidermal, 86

   junctional, 86

erythema infectiosum (Fifth’s disease), 77

Erythromycin (macrolide), 106

etanercept (Enbrel®), 131

etiologies. See diseases, etiology of

external carotid artery, 16

facial nerve (CN VII), 5, 14–15

Famciclovir, 118

Finasteride, 138

Fluconazole, 114–115

fluorescent dermatophytes, 212

focal dermal hypoplasia (Goltz)(“focal”), 212

glossopharyngeal nerve (CN IX), 5–6

green birefringence with polarized light, 212

grenz zone, 224

Griseofulvin, 115–116

hand-foot-mouth disease, 77

head and neck

   anterior cervical triangle, 18

     carotid subdivision of, 19

     muscular subdivision of, 19

     submandibular subdivision of, 18

     submental subdivision of, 18

   neck triangles, 20

   posterior cervical triangle, 20

hemostasis and diagnostics, 47–48

Henoch-Schönlein purpura (“hap”), 213

Hermansky-Pudlak syndrome (“pudlak”), 213

hexachlorophene (pHisoHex™), 30

histochemical staining, 154–155

   purpose, 154–155

   stain, 154–155

HLA associations, 213

hormone antagonists, 138

   Finasteride, 138

   Spironolactone, 138

HPV types, 61

   diseases, 61

hydroxychloroquine (Plaquenil), 127

hypoglossal nerve (CN XII), 6

immunohistochemical staining, 156

   epidermal, 156

   hemapoietic, 156–157

   mesenchymal, 156

   miscellaneous, 157

   neuroectodermal, 156

immunology, 66

immunomodulators. See systemic immunomodulators

infliximab (Remicade®), 131

internal carotid artery, 16

internal maxillary artery, 16

intraepidermal eosinophilic vesicles, 224

intravenous immunoglobulin (IVIG), 101

iodine/iodophores (Betadine), 30

isopropyl alcohol (70%), 30

Itraconazole (triazole), 113–114

Ivermectin, 139

Kawasaki disease (mucocutaneous lymph node syndrome) (“fresca”), 78, 213

keratins

   in disease, 150–151

   location, 150

   type I, 150

   type II, 150

Ketoconazole, 114

LAMB syndrome, 213

lasers and light

   infrared, 53

   terminology, 53

   ultraviolet, 53

   uv spectrum wavelengths, 54

   visible, 53

leishmaniasis, 163

   uncommon forms of, 163

LEOPARD syndrome, 214

Levofloxacin (quinolone), 108–109

lichenoid reactions, drug-induced, 210

lidocaine toxicity, 42

linear IgA dermatosis, drug-induced, 211

lists. See dermatology lists

liver biopsies (Roenigk classification), 120

local anesthesia

   alternatives, 41

   contraindications, 41

   dosing calculations, 40

   with epinephrine, 39

   without epinephrine, 39

   injectable, 40

lupus erythematosus, diagnostic criteria (“champions nd”), 214

mandibular nerve (CNV3), 12–13, 14

   auriculotemporal branch of, 12

   buccal branch of, 12

   inferior alveolar branch of, 13

mast cell degranulators (non-immunologic)(“prom”), 215

mastocytosis types (“mast”), 215

maxillary nerve (CN V2), 11

   infraorbital branch of, 11

   zygomaticofacial branch of, 11

   zygomaticotemporal branch of, 11

melanoma

   AJCC staging for cutaneous, 91

   AJCC-TNM classification, 89–90

   Clark’s and Breslow staging of, 93

   malignant, 92

     5 year survival rates for, 92

     surgical management for, 92

Methotrexate, 119

microbiology and immunology, 57–67

   complement system, 67

   DNA viruses, 59

   HPV types, 61

     diseases, 61

   immunology, 66

   mycobacteria classification, 58

   RNA viruses, 60

   smallpox

     major criteria of, 62

     minor criteria of, 62

     vaccination complications, 63

     vaccination timeline for, 62

   verrucae, candida antigen therapy for, 64

Minocycline (tetracycline), 105

mnemonics. See dermatology mnemonics

mucocutaneous leishmaniasis, 163

Muir-Torre syndrome (“sank”), 215

Mupirocin (Bactroban), 112

mycobacteria classification, 58

mycophenolate mofetil (Cellcept), 126

nail terminology, 74–75

NAME syndrome, 215

needles

   curvature of, 28

   ethicon of, 28

   length of, 28

   syneture of, 28

   type of, 28

Neomycin, 112

Netherton syndrome, 215

neurology, 7

Nicotinamide, 139–140

non-inflammatory subepidermal blister, 225

occipital artery, 16

occlusive wound dressings

   alginates, 33

   film, 32

   foam, 32

   hydroactive, 33–34

   hydrocolloid, 31–32

   hydrofiber, 34

   hydrogel, 31

   zinc paste bandages, 34

oculomotor exam

   CN III, Inferior division, 8

   CN III, Superior division, 8

   CN IV, 8

   CN VI, 8

oculomotor nerve (CN III), 4

olfactory nerve (CN I), 4

operative note, 3–4

opthalmic artery, 16

opthalmic nerve (CN V1), 11

   frontalis (supraorbital) branch of, 11

   frontalis (supratrochlear) branch of, 11

   lacrimal branch of, 11

   nasociliary (anterior ethmoidal external nasal) branch of, 11

   nasociliary (infratrochlear) branch of, 11

   nasociliary (posterior ethmoidal) branch of, 11

optic nerve (CN II), 4

pachyonychia congenita, 216

painful dermal tumors (“bengal”), 216

panniculitides, lobular, 159

   with vasculitis, 159

   without vasculitis, 159–160

panniculitides, septal, 158

   with vasculitis, 158

   without vasculitis, 158

paraneoplastic pemphigus, 153

parasitized histiocytes, 225

partial thromboplastin time (PTT; activated PTT; APTT), 47

patchy dermal lymphocytic infiltrates (“5 Ls”), 225

pediatric dermatology, 76–79

perforating disorders (“kerrp”), 216

permethrin (Elimite), 140

pigmentation, drug-induced, 211

POEMS syndrome, 216

Polymyxin B, 112

porphyrias, 83

   laboratory evaluation for, 84

posterior auricular artery, 16

pregnancy. See Varicella Zoster Virus

prothrombin time (PT/INR), 47

pseudocarcinomatous hyperplasia, 226

puritus without skin rash (“herb mend”), 216–217

PUVA therapy, 142

quinacrine (Atabrine), 127–128

Refsum’s syndrome (phytanic acid oxidase deficiency)(“crip”), 217

Rifampin, 110

Riley-Day syndrome (“didi data”), 217

RNA viruses, 60

Rombo syndrome (“bath mc”), 217

roseola, 76

rubella (German measles), 76

rubeola (measles), 76

sarcoid syndromes, 218

saturated solution of potassium iodide (SSKI), 140

scalp layers (“scalp”), 214

scarlet fever, 78

Schnitzler’s syndrome, 218

SCORTEN system, 102

   mortality rate, 102

   risk factors, 102

signs, dermatologic, 161–162

Sjögren-Larsson syndrome (“Larson”), 218

skin grafts

   full thickness (FTSG), 35

   split thickness (STSG), 35

   terminology, 35

   types of, 35

skin lesion terminology

   primary skin lesions, 73

   secondary skin lesions, 73

skin, structure/function of, 88

   anchoring filaments, 88

   lamina densa, 88

   lamina lucida, 88

   plasma membrane, 88

   sublamina densa, 88

skin types, 143

   UVA/UVB based on, 143

smallpox

   major criteria of, 62

   minor criteria of, 62

   vaccination complications, 63

   vaccination timeline for, 62

spinal accessory nerve (CN XI), 6

Spironolactone, 138

staining. See histochemical staining; immunohistochemical staining

steroidogenesis, 147

subepidermal bullae with neutrophils (“plaid”), 226

superficial temporal artery, 16

sutures

   absorbable, 27

   absorption (days), 27

   non-absorbable, 27

Sweet’s syndrome, drug-induced, 211

syndromes, 179–201

systemic antibacterials, 105–111

systemic antifungals, 113–116

systemic antivirals, 117–118

systemic cutaneous lupus erythematosus, drug-induced, 210

systemic immunomodulators, 122–123

systemic lupus erythematosus, 80

   laboratory test for, 81

systemic lupus erythematosus, drug-induced, 210

systemic retinoids, 103

   acitretin (Soriatane), 103–104

   isotretinoin (Accutane), 103

temporal nerve, 14

Terbinafine (allylamine), 113

Tetracycline (tetracycline), 105–106

Thalidomide, 141

topical anesthesia, 38

topical antimicrobials, 112

topical corticosteroids, 132–135

   high potency group (II), 132

   low potency group (VI), 134

   low potency group (VII), 135

   mid potency group (IV), 133

   mid potency group (V), 133–134

   potent group (III), 132–133

   super-high potency group (I), 132

toxic epidermal necrolysis (TEN) protocol, 97–98

triclosan, 30

trigeminal nerve (CN V), 5, 11–13

Trimethoprim-Sulfamethoxazole (TMP:SMX=1:5), 109

trochlear nerve (CN IV), 4

vagal nerve (CN X), 6

Valacyclovir, 117–118

Varicella Zoster Virus (VZV), 77

   pregnancy and, 79

vasculitis, 158, 159

verrucae, candida antigen therapy for, 64

vestibulocochlear nerve (CN VIII), 5

visceral leishmaniasis, 163

vitamins (“the rich never pay cash”), 219

Wegener’s granulomatosis (“rough”), 218

Wiskott-Aldrich (XLR inheritance)(“tie”), 219

x-linked dominant diseases, 178

   disease, 178

   gene, 178

x-linked recessive diseases, 178

   disease, 178

   gene, 178

zygomatic nerve, 14


printer iconPrinter friendly version AddThis